European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document
- PMID: 20176693
- PMCID: PMC2826099
- DOI: 10.1093/annonc/mdp471
European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document
Abstract
European Guidelines for Quality Assurance in Cervical Cancer Screening have been initiated in the Europe Against Cancer Programme. The first edition established the principles of organised population-based screening and stimulated numerous pilot projects. The second multidisciplinary edition was published in 2008 and comprises approximately 250 pages divided into seven chapters prepared by 48 authors and contributors. Considerable attention has been devoted to organised, population-based programme policies which minimise adverse effects and maximise benefits of screening. It is hoped that this expanded guidelines edition will have a greater impact on countries in which screening programmes are still lacking and in which opportunistic screening has been preferred in the past. Other methodological aspects such as future prospects of human papillomavirus testing and vaccination in cervical cancer control have also been examined in the second edition; recommendations for integration of the latter technologies into European guidelines are currently under development in a related project supported by the European Union Health Programme. An overview of the fundamental points and principles that should support any quality-assured screening programme and key performance indicators are presented here in a summary document of the second guidelines edition in order to make these principles and standards known to a wider scientific community.
Similar articles
-
European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document.Ann Oncol. 2008 Apr;19(4):614-22. doi: 10.1093/annonc/mdm481. Epub 2007 Nov 17. Ann Oncol. 2008. PMID: 18024988 Review.
-
[Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].Epidemiol Prev. 2012 May-Aug;36(3-4 Suppl 1):e1-72. Epidemiol Prev. 2012. PMID: 22828243 Italian.
-
The challenges of organising cervical screening programmes in the 15 old member states of the European Union.Eur J Cancer. 2009 Oct;45(15):2671-8. doi: 10.1016/j.ejca.2009.07.016. Epub 2009 Aug 18. Eur J Cancer. 2009. PMID: 19695867
-
Cervical cancer screening in Europe: Quality assurance and organisation of programmes.Eur J Cancer. 2015 May;51(8):950-68. doi: 10.1016/j.ejca.2015.03.008. Epub 2015 Mar 25. Eur J Cancer. 2015. PMID: 25817010
-
What's next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination.Eur J Cancer. 2009 Oct;45(15):2714-21. doi: 10.1016/j.ejca.2009.07.024. Epub 2009 Aug 18. Eur J Cancer. 2009. PMID: 19695870 Review.
Cited by
-
Long-term cervical precancer outcomes after a negative DNA- or RNA-based human papillomavirus test result.Am J Obstet Gynecol. 2021 Nov;225(5):511.e1-511.e7. doi: 10.1016/j.ajog.2021.05.038. Epub 2021 Jun 1. Am J Obstet Gynecol. 2021. PMID: 34081897 Free PMC article.
-
Utilization of cervical cancer screening among migrants and non-migrants in Germany: results from a large-scale population survey.BMC Public Health. 2020 Jan 6;20(1):5. doi: 10.1186/s12889-019-8006-4. BMC Public Health. 2020. PMID: 31906964 Free PMC article.
-
Delayed breast cancer diagnosis after repeated recall at biennial screening mammography: an observational follow-up study from the Netherlands.Br J Cancer. 2020 Jul;123(2):325-332. doi: 10.1038/s41416-020-0870-2. Epub 2020 May 11. Br J Cancer. 2020. PMID: 32390006 Free PMC article.
-
PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort.J Gynecol Oncol. 2019 May;30(3):e29. doi: 10.3802/jgo.2019.30.e29. J Gynecol Oncol. 2019. PMID: 30887754 Free PMC article.
-
Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions.BMC Cancer. 2018 Jan 30;18(1):112. doi: 10.1186/s12885-018-4033-2. BMC Cancer. 2018. PMID: 29382323 Free PMC article.
References
-
- Arbyn M, Raifu AO, Autier P, Ferlay J. Burden of cervical cancer in Europe: estimates for 2004. Ann Oncol. 2007;18:1708–1715. - PubMed
-
- Arbyn M, Autier P, Ferlay J. Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004. Ann Oncol. 2007;18:1423–1425. - PubMed
-
- Miller AB. Cervical Cancer Screening Programmes: Managerial Guidelines. Geneva, Switzerland: World Health Organisation; 1992.
-
- International Agency for Research on Cancer. IARC Handbooks of Cancer Prevention. Vol. 10: Cervix Cancer Screening. Lyon, France: IARC Press; 2005.
-
- Coleman D, Day N, Douglas G, et al. European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme. Eur J Cancer. 1993;29A(Suppl 4):S1–S38. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous